Quarterly Outlook
Q3 Investor Outlook: Beyond American shores – why diversification is your strongest ally
Jacob Falkencrone
Global Head of Investment Strategy
Summary: Today, a run down the gauntlet of risks that this market has to navigate in the coming two weeks, from earnings and US data to geopolitics and other factors as we fret that a reasonable consolidation at minimum is imminent, and even if it isn't, would further destabilize the course of future returns. A discussion of Meta reporting today, Novo Nordisk's profit warning and whether the bottom is near for that company and much more. Today's pod hosted by Saxo Global Head of Macro Strategy John J. Hardy.
Listen to the full episode now or follow Saxo Market Call on your favorite podcast app:
Meta earnings after the close will be an interesting one. A bit surprising that the IV rank only at 30%, with an “expected move” through Friday of about 5.4% as of Barchart’s snapshot. Yesterday saw an ugly sell-off bar to the round 700 level (options-linked?). As noted on the pod today, interesting to see how the market treats the stock if Zuckerberg continues further ups the capex plans on AI data centers and not least, salaries for top talent in the field. I have no insight here on what Meta will deliver - just asking questions.